3 years ago

Blockade of Metabotropic GABA-B Receptors as an Approach to Reduce Toxic Peripheral Effects of Cholinesterase Inhibitors

O. A. Lenina, P. Masson, K. A. Petrov


The application of organophosphate (OP) pesticides in agriculture, in addition to the existence of chemical warfare nerve agents and their possible use in terrorist acts is a significant threat to populations all over the world. Moreover, treatment of OP poisoning is still imperfect. Here, we studied the effect of blockade of metabotropic GABA-B receptors by compound CGP55845 (10 μM) on the force of muscle contractions when cholinesterases are inhibited by paraoxon. It was shown that CGP55845 prevented the decrease in the force of diaphragm muscle contractions caused by paraoxon ex vivo. Moreover, for in vivo experiments, GABA-B receptor blocker CGP36742 at the doses 30 and 100 mg/kg was used. It was shown that CGP36742 is able to reduce the lethality of mice after OP challenge. Thus, GABA-B receptor blockers can be considered as additional medications, which can complement the current therapy of acute poisoning by cholinesterase inhibitors.

Publisher URL: https://link.springer.com/article/10.1007/s12668-018-0572-x

DOI: 10.1007/s12668-018-0572-x

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.